183 related articles for article (PubMed ID: 22155248)
1. Sulfated, low molecular weight lignins inhibit a select group of heparin-binding serine proteases.
Henry BL; Thakkar JN; Liang A; Desai UR
Biochem Biophys Res Commun; 2012 Jan; 417(1):382-6. PubMed ID: 22155248
[TBL] [Abstract][Full Text] [Related]
2. Sulfated low molecular weight lignins, allosteric inhibitors of coagulation proteinases via the heparin binding site, significantly alter the active site of thrombin and factor xa compared to heparin.
Henry BL; Desai UR
Thromb Res; 2014 Nov; 134(5):1123-9. PubMed ID: 25242245
[TBL] [Abstract][Full Text] [Related]
3. Sulfated, low-molecular-weight lignins are potent inhibitorsof plasmin, in addition to thrombin and factor Xa: Novel opportunity for controlling complex pathologies.
Henry BL; Abdel Aziz M; Zhou Q; Desai UR
Thromb Haemost; 2010 Mar; 103(3):507-15. PubMed ID: 20024500
[TBL] [Abstract][Full Text] [Related]
4. Identification of the site of binding of sulfated, low molecular weight lignins on thrombin.
Abdel Aziz MH; Mosier PD; Desai UR
Biochem Biophys Res Commun; 2011 Sep; 413(2):348-52. PubMed ID: 21893043
[TBL] [Abstract][Full Text] [Related]
5. Dynamic affinity chromatography in the separation of sulfated lignins binding to thrombin.
Liang A; Thakkar JN; Hindle M; Desai UR
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Nov; 908():45-51. PubMed ID: 23122400
[TBL] [Abstract][Full Text] [Related]
6. Development of Trypsin-Like Serine Protease Inhibitors as Therapeutic Agents: Opportunities, Challenges, and their Unique Structure-Based Rationales.
Liang G; Bowen JP
Curr Top Med Chem; 2016; 16(13):1506-29. PubMed ID: 26369819
[TBL] [Abstract][Full Text] [Related]
7. Interaction of antithrombin with sulfated, low molecular weight lignins: opportunities for potent, selective modulation of antithrombin function.
Henry BL; Connell J; Liang A; Krishnasamy C; Desai UR
J Biol Chem; 2009 Jul; 284(31):20897-908. PubMed ID: 19497853
[TBL] [Abstract][Full Text] [Related]
8. Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin.
Olson ST; Swanson R; Raub-Segall E; Bedsted T; Sadri M; Petitou M; Hérault JP; Herbert JM; Björk I
Thromb Haemost; 2004 Nov; 92(5):929-39. PubMed ID: 15543318
[TBL] [Abstract][Full Text] [Related]
9. Substantial non-electrostatic forces are needed to induce allosteric disruption of thrombin's active site through exosite 2.
Mehta AY; Desai UR
Biochem Biophys Res Commun; 2014 Sep; 452(3):813-6. PubMed ID: 25201728
[TBL] [Abstract][Full Text] [Related]
10. Mechanism-based isocoumarin inhibitors for blood coagulation serine proteases. Effect of the 7-substituent in 7-amino-4-chloro-3-(isothioureidoalkoxy)isocoumarins on inhibitory and anticoagulant potency.
Kam CM; Kerrigan JE; Plaskon RR; Duffy EJ; Lollar P; Suddath FL; Powers JC
J Med Chem; 1994 Apr; 37(9):1298-306. PubMed ID: 8176707
[TBL] [Abstract][Full Text] [Related]
11. Studies on fragment-based design of allosteric inhibitors of human factor XIa.
Boothello RS; Sankaranarayanan NV; Afosah DK; Karuturi R; Al-Horani RA; Desai UR
Bioorg Med Chem; 2020 Dec; 28(23):115762. PubMed ID: 32992249
[TBL] [Abstract][Full Text] [Related]
12. Designing allosteric regulators of thrombin. Exosite 2 features multiple subsites that can be targeted by sulfated small molecules for inducing inhibition.
Sidhu PS; Abdel Aziz MH; Sarkar A; Mehta AY; Zhou Q; Desai UR
J Med Chem; 2013 Jun; 56(12):5059-70. PubMed ID: 23718540
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a novel, potent, and specific family of factor Xa inhibitors via combinatorial chemistry.
Ostrem JA; al-Obeidi F; Safar P; Safarova A; Stringer SK; Patek M; Cross MT; Spoonamore J; LoCascio JC; Kasireddy P; Thorpe DS; Sepetov N; Lebl M; Wildgoose P; Strop P
Biochemistry; 1998 Jan; 37(4):1053-9. PubMed ID: 9454596
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in serine protease inhibitors as anticoagulant agents.
Prezelj A; Anderluh PS; Peternel L; Urleb U
Curr Pharm Des; 2007; 13(3):287-312. PubMed ID: 17313362
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of serine proteinases from blood coagulation cascade - view on current developments.
Danalev D
Mini Rev Med Chem; 2012 Jul; 12(8):721-30. PubMed ID: 22512557
[TBL] [Abstract][Full Text] [Related]
16. A novel allosteric pathway of thrombin inhibition: Exosite II mediated potent inhibition of thrombin by chemo-enzymatic, sulfated dehydropolymers of 4-hydroxycinnamic acids.
Henry BL; Monien BH; Bock PE; Desai UR
J Biol Chem; 2007 Nov; 282(44):31891-9. PubMed ID: 17804413
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the anticoagulant activity of cyclic sulfated glycosaminoglycan mimetics.
Chiles R; Afosah DK; Al-Horani RA
Carbohydr Res; 2023 Jul; 529():108831. PubMed ID: 37209666
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulant and antiprotease activities of a heparinoid sulfated glucoside-bearing polymer.
Onishi M; Miyashita Y; Motomura T; Yamashita S; Sakamoto N; Akashi M
J Biomater Sci Polym Ed; 1998; 9(9):973-84. PubMed ID: 9747989
[TBL] [Abstract][Full Text] [Related]
19. Novel low molecular weight lignins as potential anti-emphysema agents: In vitro triple inhibitory activity against elastase, oxidation and inflammation.
Saluja B; Thakkar JN; Li H; Desai UR; Sakagami M
Pulm Pharmacol Ther; 2013 Apr; 26(2):296-304. PubMed ID: 23280431
[TBL] [Abstract][Full Text] [Related]
20. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
Melo FR; Mourão PA
Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
